Jpmorgan Chase & CO Surrozen, Inc. Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.89 $11 - $22	25 New	25 $0
Q3 2022 Nov 14, 2022	BUY	$0.26 - $46.35 $0 - $139	3 New	3 $0
Q2 2022 Aug 11, 2022	SELL	$2.14 - $3.43 $111 - $178	-52 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$2.2 - $6.01 $114 - $312	52 New	52 $0
Q4 2021 Feb 10, 2022	SELL	$6.0 - $9.92 $2,502 - $4,136	-417 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.98 - $12.03 $2,910 - $5,016	417 New	417 $3,000

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $358M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.